Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                ESG Next Generation

ESG Next Generation

                        Comparison of Current ESG & ESG NextGen
          ESG NextGen Timeline
          ESG NextGen Submission Process
          ESG NextGen Draft API Specification
          ESG NextGen Frequently Asked Questions
          What's New Home
          For Industry
          ESG Next Generation
          ESG NextGen Frequently Asked QuestionsESG Next Generation ESG NextGen Frequently Asked Questions
  
  	
    Share
    Post
    Linkedin

    Email
    PrintESG NextGen Frequently Asked Questions (FAQs)

Am I able to use my current submission packaging process?
	Will I be able to continue using AS2 for submitting?
	How soon will the ESG NextGen be available for Industry testing?
	What kind of authentication and certifications will be required before writing to the API?
	Does the Agency anticipate any changes in the transmission of xml files or tar.gz files?
	Will the ESG NextGen API follow current Internet standards that can be implemented by current vendors, like AS2 does?
	In recognizing that the ESG NextGen will enable new functionalities and employ an API, could the Agency provide details on any direct impact to users that users need to be aware of (e.g., updates/changes to digital certificates and credentials)?
	FDA mentioned at the February Quarterly meeting that the ESG NextGen will be agnostic to data types and will be able to ingest different file types. Is the planned scope of the ESG NextGen broader than the current ESG? Will the ESG NextGen be used for eCTD submissions only or will non-eCTD submissions be sent through the ESG NextGen as well?
	Has the Agency performed any submission testing in the new environment? Can the Agency share information regarding the capabilities of the ESG NextGen (e.g., submission size and file size limitations)?
	The current ESG has provided some new administrative functions through the Account Portal for WebTrader users. Will the API have similar/same administrative functionality for all users (i.e., current WebTrader and AS2 users)?


**Question:** Am I able to use my current submission packaging process?

	**Answer:** Sponsors can continue to use eSubmitter or other existing methods to package their submissions for upload to ESG NextGen.
	**Question:** Will I be able to continue using AS2 for submitting?

	**Answer:** ESG NextGen will provide an API method to facilitate system-to-system file submissions.
	**Question:** How soon will the ESG NextGen be available for Industry testing?

	**Answer:** As seen on the Timeline page, Q2/Q3 of FY24 will be the Industry’s opportunity to test their submissions on ESG NextGen. FDA will publish a more definitive timeline for testing in the coming months.
	**Question:** What kind of authentication and certifications will be required before writing to the API?

	**Answer:** FDA plans to use Client ID and Secret key for API authentication and OAuth for API authorization. Both are widely used approaches for API security. Users will need to login to the ESG Unified Submission Portal and/or use the API to register and obtain API Client ID and Secret key before using APIs.
	**Question:** Does the Agency anticipate any changes in the transmission of xml files or tar.gz files?

	**Answer:** No, FDA does not anticipate any changes in the transmission of said files.
	**Question:** Will the ESG NextGen API follow current Internet standards that can be implemented by current vendors, like AS2 does?

	**Answer:** The APIs will be built using the RESTful standard. FDA will publish API specifications for industry review close to the time of the demo (July).
	**Question:** In recognizing that the ESG NextGen will enable new functionalities and employ an API, could the Agency provide details on any direct impact to users that users need to be aware of (e.g., updates/changes to digital certificates and credentials)?

	**7.A. Answer:** FDA plans to provide APIs for variety of tasks in ESG NextGen, including initial and subsequent submissions, status inquiries, and other service functions to facilitate submission programmatically.**7.B. Answer:** FDA plans to replace the digital certificate with the FDA ICAM services, electronic signature, and Client ID/Secret key for API authentication and other credential needs.
	**Question:** FDA mentioned at the February Quarterly meeting that the ESG NextGen will be agnostic to data types and will be able to ingest different file types. Is the planned scope of the ESG NextGen broader than the current ESG? Will the ESG NextGen be used for eCTD submissions only or will non-eCTD submissions be sent through the ESG NextGen as well?

	**8.A. Answer:** FDA plans to offer broader ESG NextGen capabilities to enhance experience in user onboarding and management, submission preparation, large file upload, status tracking, two-way communication and user assistance. These capabilities will be rolled out in a phased approach. In the first phase, FDA plans to replace WebTrader with the new Unified Submission Portal that will work with major Browsers such as Google Chrome, Microsoft Edge, Apple Safari, etc.**8.B. Answer:** ESG NextGen is designed to be agnostic to file types and will work with all file types currently supported by ESG. FDA currently does not have plan to support additional file types. New file types will be determined by the Centers and will be announced prior to FDA adopting the use. As before, ESG NextGen will accept both eCTD and non-eCTD submissions.
	**Question:** Has the Agency performed any submission testing in the new environment? Can the Agency share information regarding the capabilities of the ESG NextGen (e.g., submission size and file size limitations)?

	**Answer:** FDA is currently developing the Proof-of-Concept on some key functional areas. Performance testing is in the plan. FDA will share the new capacities such as file size limitation once they become available.
	**Question:** The current ESG has provided some new administrative functions through the Account Portal for WebTrader users. Will the API have similar/same administrative functionality for all users (i.e., current WebTrader and AS2 users)?

	**Answer:** Most likely, yes. ESG NextGen will provide and extend current ESG functionality as it pertains to account administration and file submissions in the Unified Submission Portal.

**To provide feedback, please email EsgNgSupport@fda.hhs.gov**

Back to Top

                                                                                  Content current as of:
      07/14/2023ESG Next Generation

          
                        ESG & ESG NextGen Comparison
          ESG NextGen Timeline
          ESG NextGen Submission Process
          Draft API Specification
          Frequently Asked Questions (FAQs)
          What's New
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop